{"id":"https://openalex.org/W2018653124","doi":"https://doi.org/10.1016/s1359-6349(08)71412-5","title":"Individual and collective cancer cell invasion","display_name":"Individual and collective cancer cell invasion","publication_year":2008,"publication_date":"2008-07-01","ids":{"openalex":"https://openalex.org/W2018653124","doi":"https://doi.org/10.1016/s1359-6349(08)71412-5","mag":"2018653124"},"language":"en","primary_location":{"id":"doi:10.1016/s1359-6349(08)71412-5","doi":"https://doi.org/10.1016/s1359-6349(08)71412-5","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s1359-6349(08)71412-5","pdf_url":null,"source":{"id":"https://openalex.org/S13410216","display_name":"European Journal of Cancer Supplements","issn_l":"1359-6349","issn":["1359-6349","1878-1217"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","jufo-1","norway-1","poland-100","russia-white-list-4"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Cancer Supplements","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref","doaj"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026527299","display_name":"Peter Friedl","orcid":"https://orcid.org/0000-0002-0119-4041","observed_orcids":["https://orcid.org/0000-0002-0119-4041"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"P. Friedl","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5026527299"],"corresponding_institution_ids":[],"apc_list":{"value":0,"currency":"USD","value_usd":0},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"6","issue":"9","first_page":"62","last_page":"62"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10816","display_name":"Cerebrovascular and Carotid Artery Diseases","score":0.6298999786376953,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10816","display_name":"Cerebrovascular and Carotid Artery Diseases","score":0.6298999786376953,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12955","display_name":"Atherosclerosis and Cardiovascular Diseases","score":0.22789999842643738,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.06159999966621399,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tenascin-c","display_name":"tenascin-C","score":0.8730000257492065},{"id":"https://openalex.org/keywords/fibronectin","display_name":"fibronectin","score":0.9210000038146973},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.847000002861023},{"id":"https://openalex.org/keywords/atherosclerosis","display_name":"atherosclerosis","score":0.7070000171661377},{"id":"https://openalex.org/keywords/carotid-plaque","display_name":"carotid plaque","score":0.8379999995231628},{"id":"https://openalex.org/keywords/tissue-remodeling","display_name":"tissue remodeling","score":0.746999979019165},{"id":"https://openalex.org/keywords/macrophages","display_name":"macrophages","score":0.7409999966621399},{"id":"https://openalex.org/keywords/vasa-vasorum","display_name":"vasa vasorum","score":0.9959999918937683},{"id":"https://openalex.org/keywords/ki-67","display_name":"Ki-67","score":0.7829999923706055},{"id":"https://openalex.org/keywords/radioimmunoconjugates","display_name":"radioimmunoconjugates","score":0.7429999709129333},{"id":"https://openalex.org/keywords/immunocytokines","display_name":"immunocytokines","score":0.8569999933242798},{"id":"https://openalex.org/keywords/targeted-drug-delivery","display_name":"targeted drug delivery","score":0.6809999942779541},{"id":"https://openalex.org/keywords/plaque-imaging","display_name":"plaque imaging","score":0.6549999713897705}],"concepts":[{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.6858826875686646},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3459949195384979},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.16128244996070862}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s1359-6349(08)71412-5","doi":"https://doi.org/10.1016/s1359-6349(08)71412-5","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s1359-6349(08)71412-5","pdf_url":null,"source":{"id":"https://openalex.org/S13410216","display_name":"European Journal of Cancer Supplements","issn_l":"1359-6349","issn":["1359-6349","1878-1217"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","jufo-1","norway-1","poland-100","russia-white-list-4"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Cancer Supplements","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2034368164","https://openalex.org/W2108083745","https://openalex.org/W2116239015","https://openalex.org/W2148556520","https://openalex.org/W2159930023","https://openalex.org/W7001015258","https://openalex.org/W2059969591","https://openalex.org/W2077610922","https://openalex.org/W2112218358","https://openalex.org/W2414307621"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-08-21T09:56:20.448147","created_date":"2016-06-24T00:00:00"}